Hepatic lipase and dyslipidemia: Interactions among genetic variants, obesity, gender, and diet

Journal of Lipid Research

Volumn 44, Issue 7, 2003, Pages 1279-1286

  Deeb, Samir S ^a   Zambon, Alberto ^b   Carr, Molly C ^b   Ayyobi, Amir F ^b   Brunzell, John D ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Atherosclerosis; Hepatic lipase genetics; Hyperlipidemia

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN;

DIET; DNA POLYMORPHISM; DYSLIPIDEMIA; ENZYME ACTIVITY; FAMILIAL HYPERLIPEMIA; FAT INTAKE; GENDER; GENETIC VARIABILITY; HUMAN; INSULIN RESISTANCE; LIPID METABOLISM; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROMOTER REGION; REVIEW;

DIABETES MELLITUS, TYPE 2; DIET; FEMALE; HAPLOTYPES; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; HYPERLIPIDEMIAS; LIPASE; LIPOPROTEINS, LDL; LIVER; MALE; MODELS, BIOLOGICAL; OBESITY; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); SEX FACTORS; VARIATION (GENETICS);

EID: 0142074269     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.R200017-JLR200     Document Type: Review

References (79)

1. Brunzell, J. D., and S. Deeb. 2001. Lipoprotein lipase, apolipoprotein CII and hepatic lipase deficiencies. In The Molecular and Metabolic Bases of Inherited Disease. 8th Edition. C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle, editors. McGraw-Hill, New York. 2789-2816.
2. Wong, H., and M. C. Schotz. 2002. The lipase gene family. J. Lipid Res. 43: 993-999.
3. Perret, B., L. Mabile, L. Martinez, F. Terce, R. Barbaras, and X. Collet. 2002. Hepatic lipase: structure/function relationship, synthesis, and regulation. J. Lipid Res. 43: 1163-1169.
4. Jansen, H., A. J. Verhoeven, and E. J. Sijbrands. 2002. Hepatic lipase: a pro- or anti-atherogenic protein? J. Lipid Res. 43: 1352-1362.
5. Applebaum-Bowden, D. 1995. Lipases and lecithin:cholesterol acyl-transferase in the control of lipoprotein metabolism. Curr. Opin. Lipidol. 6: 130-135.
6. Santamarina-Fojo, S., C. Haudenschild, and M. Amar. 1998. The role of hepatic lipase in lipoprotein metabolism and atherosclerosis. Curr. Opin. Lipidol. 9: 211-219.
7. Zambon, A., M. A. Austin, B. G. Brown, J. E. Hokanson, and J. D. Brunzell. 1993. Effect of hepatic lipase on LDL in normal men and those with coronary artery disease. Arterioscler. Thromb. 13: 147-153.
8. Watson, T. D., M. J. Caslake, D. J. Freeman, B. A. Griffin, J. Hinnie, C. J. Packard, and J. Shepherd. 1994. Determinants of LDL sub-fraction distribution and concentrations in young normolipidemic subjects. Arterioscler. Thromb. 14: 902-910.
9. Vega, G. L., and S. M. Grundy. 1998. Effect of statins on metabolism of apo-B-containing lipoproteins in hypertriglyceridemic men. Am. J. Cardiol. 81: 36B-42B.
10. Jansen, H., W. Hop, A. van Tol, A. V. Bruschke, and J. C. Birkenhager. 1994. Hepatic lipase and lipoprotein lipase are not major determinants of the low density lipoprotein subclass pattern in human subjects with coronary heart disease. Atherosclerosis. 107: 45-54.
11. Hegele, R. A., J. A. Little, C. Vezina, G. F. Maguire, L. Tu, T. S. Wolever, D. J. Jenkins, and P. W. Connelly. 1993. Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics. Arterioscler. Thromb. 13: 720-728.
12. Auwerx, J. A., C. A. Marzetta, J. E. Hokanson, and J. D. Brunzell. 1989. Large buoyant LDL-like particles in hepatic lipase deficiency. Arteriosclerosis. 9: 319-325.
13. Zambon, A., S. S. Deeb, A. Bensadoun, K. E. Foster, and J. D. Brunzell. 2000. In vivo evidence of a role for hepatic lipase in human apoB-containing lipoprotein metabolism, independent of its lipolytic activity. J. Lipid Res. 41: 2094-2099.
14. Bamberger, M., S. Lund-Katz, M. C. Phillips, and G. H. Rothblat. 1985. Mechanism of the hepatic lipase induced accumulation of high-density, lipoprotein cholesterol by cells in culture. Biochemistry. 24: 3693-3701.
15. Kuusi, T., P. Saarinen, and E. A. Nikkila. 1980. Evidence for the role of hepatic endothelial lipase in the metabolism of plasma high density lipoprotein2 in man. Atherosclerosis. 36: 589-593.
16. Cominacini, L., U. Garbin, A. Davoli, M. Campagnola, A. De Santis, C. Pasini, A. M. Pastorino, and O. Bosello. 1993. High-density lipoprotein cholesterol concentrations and postheparin hepatic and lipoprotein lipases in obesity: relationships with plasma insulin levels. Ann. Nutr. Metab. 37: 175-184.
17. Blades, B., G. L. Vega, and S. M. Grundy. 1993. Activities of lipoprotein lipase and hepatic triglyceride lipase in postheparin plasma of patients with low concentrations of HDL cholesterol. Arterioscler. Thromb. 13: 1227-1235.
18. Applebaum, D. M., A. P. Goldberg, O. J. Pykalisto, J. D. Brunzell, and W. R. Hazzard. 1977. Effect of estrogen on post-heparin lipolytic activity. Selective decline in hepatic triglyceride lipase. J. Clin. Invest. 59: 601-608.
19. Brinton, E. A. 1996. Oral estrogen replacement therapy in post-menopausal women selectively raises levels and production rates of lipoprotein A-I and lowers hepatic lipase activity without lowering the fractional catabolic rate. Arterioscler. Thromb. Vasc. Biol. 16: 431-440.
20. Thuren, T. 2000. Hepatic lipase and HDL metabolism. Curr. Opin. Lipidol. 11: 277-283.
21. Zambon, A., S. S. Deeb, J. E. Hokanson, B. G. Brown, and J. D. Brunzell. 1998. Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterol. Arterioscler. Thromb. Vasc. Biol. 18: 1723-1729.
22. Cohen, J. C., G. L. Vega, and S. M. Grundy. 1999. Hepatic lipase: new insights from genetic and metabolic studies. [In Process Citation] Curr. Opin. Lipidol. 10: 259-267.
23. Oram, J. F., and S. Yokoyama. 1996. Apolipoprotein-mediated removal of cellular cholesterol and phospholipids. J. Lipid Res. 37: 2473-2491.
24. Mowri, H. O., J. R. Patsch, A. M. Gotto, Jr., and W. Patsch. 1996. Apolipoprotein A-II influences the substrate properties of human HDL2 and HDL3 for hepatic lipase. Arterioscler Thromb. Vasc. Biol. 16: 755-762.
25. Cheung, M. C., B. G. Brown, A. C. Wolf, and J. J. Albers. 1991. Altered particle size distribution of apolipoprotein A-I-containing lipoproteins in subjects with coronary artery disease. J. Lipid Res. 32: 383-394.
26. Julve, J., J. C. Escola-Gil, V. Ribas, F. Gonzalez-Sastre, J. Ordonez-Llanos, J. L. Sanchez-Quesada, and F. Blanco-Vaca. 2002. Mechanisms of HDL deficiency in mice overexpressing human apoA-II. J. Lipid Res. 43: 1734-1742.
27. Krieger, M. 2001. Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systems. J. Clin. Invest. 108: 793-797.
28. Lambert, G., M. B. Chase, K. Dugi, A. Bensadoun, H. B. Brewer, Jr., and S. Santamarina-Fojo. 1999. Hepatic lipase promotes the selective uptake of high density lipoprotein-cholesteryl esters via the scavenger receptor B1. J. Lipid Res. 40: 1294-1303.
29. Krapp, A., S. Ahle, S. Kersting, Y. Hua, K. Kneser, M. Nielsen, J. Gliemann, and U. Beisiegel. 1996. Hepatic lipase mediates the uptake of chylomicrons and beta-VLDL into cells via the LDL receptor-related protein (LRP). J. Lipid Res. 37: 926-936.
30. Ji, Z. S., H. L. Dichek, R. D. Miranda, and R. W. Mahley. 1997. Heparan sulfate proteoglycans participate in hepatic lipase and apolipoprotein E-mediated binding and uptake of plasma lipoproteins, including high density lipoproteins. J. Biol. Chem. 272: 31285-31292.
31. Huff, M. W., D. B. Miller, B. M. Wolfe, P. W. Connelly, and C. G. Sawyez. 1997. Uptake of hypertriglyceridemic very low density lipoproteins and their remnants by HepG2 cells: the role of lipoprotein lipase, hepatic triglyceride lipase, and cell surface proteoglycans. J. Lipid Res. 38: 1318-1333.
32. Dichek, H. L., W. Brecht, J. Fan, Z. S. Ji, S. P. McCormick, H. Akeefe, L. Conzo, D. A. Sanan, K. H. Weisgraber, S. G. Young, J. M. Taylor, and R. W. Mahley. 1998. Overexpression of hepatic lipase in transgenic mice decreases apolipoprotein B-containing and high density lipoproteins. Evidence that hepatic lipase acts as a ligand for lipoprotein uptake. J. Biol. Chem. 273: 1896-1903.
33. Dugi, K. A., M. J. Amar, C. C. Haudenschild, R. D. Shamburek, A. Bensadoun, R. F. Hoyt, Jr., J. Fruchart-Najib, Z. Madj, H. B. Brewer, Jr., and S. Santamarina-Fojo. 2000. In vivo evidence for both lipolytic and nonlipolytic function of hepatic lipase in the metabolism of HDL. Arterioscler. Thromb. Vasc. Biol. 20: 793-800.
34. Heller, D. A., U. de Faire, N. L. Pedersen, G. Dahlen, and G. E. McClearn. 1993. Genetic and environmental influences on serum lipid levels in twins. N. Engl. J. Med. 328: 1150-1156.
35. Jansen, H., A. J. Verhoeven, L. Weeks, J. J. Kastelein, D. J. Halley, A. van den Ouweland, J. W. Jukema, J. C. Seidell, and J. C. Birkenhager. 1997. Common C-to-T substitution at position -480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients. Arterioscler. Thromb. Vasc. Biol. 17: 2837-2842.
36. Murtomaki, S., E. Tahvanainen, M. Antikainen, L. Tiret, V. Nicaud, H. Jansen, and C. Ehnholm. 1997. Hepatic lipase gene polymorphisms influence plasma HDL levels. Results from Finnish EARS participants. European Atherosclerosis Research Study. Arterioscler. Thromb. Vasc. Biol. 17: 1879-1884.
37. Tahvanainen, E., M. Syvanne, M. H. Frick, S. Murtomaki-Repo, M. Antikainen, Y. A. Kesaniemi, H. Kauma, A. Pasternak, M. R. Taskinen, and C. Ehnholm. 1998. Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Investigators. J. Clin. Invest. 101: 956-960.
38. Vega, G. L., L. T. Clark, A. Tang, S. Marcovina, S. M. Grundy, and J. C. Cohen. 1998. Hepatic lipase activity is lower in African American men than in white American men: effects of 5′ flanking polymorphism in the hepatic lipase gene (LIPC). J. Lipid Res. 39: 228-232.
39. Juo, S. H., Z. Han, J. D. Smith, L. Colangelo, and K. Liu. 2001. Promoter polymorphisms of hepatic lipase gene influence HDL(2) but not HDL(3) in African American men: CARDIA study. J. Lipid Res. 42: 258-264.
40. Deeb, S. S., and R. Peng. 2000. The C-514T polymorphism in the human hepatic lipase gene promoter diminishes its activity. J. Lipid Res. 41: 155-158.
41. Botma, G. J., A. J. Verhoeven, and H. Jansen. 2001. Hepatic lipase promoter activity is reduced by the C-480T and C-216A substitutions present in the common LIPC gene variant, and is increased by Upstream Stimulatory Factor. Atherosclerosis. 154: 625-632.
42. Haffner, S. M., R. D'Agostino, Jr., D. Goff, B. Howard, A. Festa, M. F. Saad, and L. Mykkanen. 1999. LDL size in African Americans, Hispanics, and non-Hispanic whites: the insulin resistance atherosclerosis study. Arterioscler. Thromb. Vasc. Biol. 19: 2234-2240.
43. Despres, J. P., M. Ferland, S. Moorjani, A. Nadeau, A. Tremblay, P. J. Lupien, G. Theriault, and C. Bouchard. 1989. Role of hepatic-triglyceride lipase activity in the association between intra-abdominal fat and plasma HDL cholesterol in obese women. Arteriosclerosis. 9: 485-492.
44. Carr, M. C., J. E. Hokanson, S. S. Deeb, J. Q. Purnell, E. S. Mitchell, and J. D. Brunzell. 1999. A hepatic lipase gene promoter polymorphism attenuates the increase in hepatic lipase activity with increasing intra-abdominal fat in women. Arterioscler. Thromb. Vasc. Biol. 19: 2701-2707.
45. Purnell, J. Q., S. E. Kahn, J. J. Albers, D. N. Nevin, J. D. Brunzell, and R. S. Schwartz. 2000. Effect of weight loss with reduction of intra-abdominal fat on lipid metabolism in older men. J. Clin. Endocrinol. Metab. 85: 977-982.
46. Despres, J. P., C. Couillard, J. Gagnon, J. Bergeron, A. S. Leon, D. C. Rao, J. S. Skinner, J. H. Wilmore, and C. Bouchard. 2000. Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) family study. [see comments] Arterioscler. Thromb. Vasc. Biol. 20: 1932-1938.
47. Huttunen, J. K., C. Ehnholm, M. Kekki, and E. A. Nikkila. 1976. Post-heparin plasma lipoprotein lipase and hepatic lipase in normal subjects and in patients with hypertriglyceridaemia: correlations to sex, age and various parameters of triglyceride metabolism. Clin. Sci. Mol. Med. 50: 249-260.
48. Applebaum-Bowden, D., S. M. Haffner, P. W. Wahl, J. J. Hoover, G. R. Warnick, J. J. Albers, and W. R. Hazzard. 1985. Postheparin plasma triglyceride lipases. Relationships with very low density lipoprotein triglyceride and high density lipoprotein2 cholesterol. Arteriosclerosis. 5: 273-282.
49. Tan, C. E., L. Foster, M. J. Caslake, D. Bedford, T. D. Watson, M. McConnell, C. J. Packard, and J. Shepherd. 1995. Relations between plasma lipids and postheparin plasma lipases and VLDL and LDL subfraction patterns in normolipemic men and women. Arterioscler. Thromb. Vasc. Biol. 15: 1839-1848.
50. Carr, M. C., J. E. Hokanson, A. Zambon, S. S. Deeb, P. H. Barrett, J. Q. Purnell, and J. D. Brunzell. 2001. The contribution of intraabdominal fat to gender differences in hepatic lipase activity and low/high density lipoprotein heterogeneity. J. Clin. Endocrinol. Metab. 86: 2831-2837.
51. St-Amand, J., J. P. Despres, S. Lemieux, B. Lamarche, S. Moorjani, D. Prud'homme, C. Bouchard, and P. J. Lupien. 1995. Does lipoprotein or hepatic lipase activity explain the protective lipoprotein profile of premenopausal women? Metabolism. 44: 491-498.
52. Tikkanen, M. J., E. A. Nikkila, T. Kuusi, and S. U. Sipinen. 1982. High density lipoprotein-2 and hepatic lipase: reciprocal changes produced by estrogen and norgestrel. J. Clin. Endocrinol. Metab. 54: 1113-1117.
53. Carlson, L. A., and M. Ericsson. 1975. Quantitative and qualitative serum lipoprotein analysis. Part 2. Studies in male survivors of myocardial infarction. Atherosclerosis. 21: 435-450.
54. Heiss, G., I. Tamir, C. E. Davis, H. A. Tyroler, B. M. Rifkand, G. Schonfeld, D. Jacobs, and I. D. Frantz, Jr. 1980. Lipoprotein-cholesterol distributions in selected North American populations: the lipid research clinics program prevalence study. Circulation. 61: 302-315.
55. McNamara, J. R., H. Campos, J. M. Ordovas, J. Peterson, P. W. Wilson, and E. J. Schaefer. 1987. Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution. Results from the Framingham Offspring Study. Arteriosclerosis. 7: 483-490.
56. Austin, M. A., J. L. Breslow, C. H. Hennekens, J. E. Buring, W. C. Willett, and R. M. Krauss. 1988. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA. 260: 1917-1921.
57. Tikkanen, M. J., and E. A. Nikkila. 1987. Regulation of hepatic lipase and serum lipoproteins by sex steroids. Am. Heart J. 113: 562-567.
58. Tikkanen, M. J., T. Kuusi, E. A. Nikkila, and U. H. Stenman. 1986. Variation of postheparin plasma hepatic lipase by menstrual cycle. Metabolism. 35: 99-104.
59. Alvarez, J. J., A. Montelongo, A. Iglesias, M. A. Lasuncion, and E. Herrera. 1996. Longitudinal study on lipoprotein profile, high density lipoprotein subclass, and postheparin lipases during gestation in women. J. Lipid Res. 37: 299-308.
60. Ikenoue, N., A. Wakatsuki, and Y. Okatani. 1999. Small low-density lipoprotein particles in women with natural or surgically induced menopause. Obstet. Gynecol. 93: 566-570.
61. Berg, G. A., N. Siseles, A. I. Gonzalez, O. C. Ortiz, A. Tempone, and R. W. Wikinski. 2001. Higher values of hepatic lipase activity in postmenopause: relationship with atherogenic intermediate density and low density lipoproteins. Menopause. 8: 51-57.
62. Sorva, R., T. Kuusi, L. Dunkel, and M. R. Taskinen. 1988. Effects of endogenous sex steroids on serum lipoproteins and postheparin plasma lipolytic enzymes. J. Clin. Endocrinol. Metab. 66: 408-413.
63. Tikkanen, M. J., E. A. Nikkila, and E. Vartiainen. 1978. Natural oestrogen as an effective treatment for type-II hyperlipoproteinaemia in postmenopausal women. Lancet. 2: 490-491.
64. Ehnholm, C., J. K. Huttunen, P. J. Kinnunen, T. A. Miettinen, and E. A. Nikkila. 1975. Effect of oxandrolone treatment on the activity of lipoprotein lipase, hepatic lipase and phospholipase A1 of human postheparin plasma. N. Engl. J. Med. 292: 1314-1317.
65. Taggart, H. M., D. Applebaum-Bowden, S. Haffner, G. R. Warnick, M. C. Cheung, J. J. Albers, C. H. Chestnut III, and W. R. Hazzard. 1982. Reduction in high density lipoproteins by anabolic steroid (stanozolol) therapy for postmenopausal osteoporosis. Metabolism. 31: 1147-1152.
66. Tikkanen, M. J., E. A. Nikkila, T. Kuusi, and S. Sipinen. 1982. Effects of oestradiol and levonorgestrel on lipoprotein lipids and postheparin plasma lipase activities in normolipoproteinaemic women. Acta Endocrinol. (Copenh.) 99: 630-635.
67. Colvin, P. L., Jr., B. J. Auerbach, L. D. Case, W. R. Hazzard, and D. Applebaum-Bowden. 1991. A dose-response relationship between sex hormone-induced change in hepatic triglyceride lipase and high-density lipoprotein cholesterol in postmenopausal women. Metabolism. 40: 1052-1056.
68. Kuusi, T., E. A. Nikkila, M. J. Tikkanen, and S. Sipinen. 1985. Effects of two progestins with different androgenic properties on hepatic endothelial lipase and high density lipoprotein2. Atherosclerosis. 54: 251-262.
69. Somekawa, Y., H. Umeki, K. Kobayashi, S. Tomura, T. Aso, and H. Hamaguchi. 2002. Effects of hormone replacement therapy and hepatic lipase polymorphism on serum lipid profiles in postmenopausal Japanese women. J. Clin. Endocrinol. Metab. 87: 4766-4770.
70. Jones, D. R., R. J. Schmidt, R. T. Pickard, P. S. Foxworthy, and P. I. Eacho. 2002. Estrogen receptor-mediated repression of human hepatic lipase gene transcription. J. Lipid Res. 43: 383-391.
71. Lemieux, S., D. Prud'homme, C. Bouchard, A. Tremblay, and J. P. Despres. 1993. Sex differences in the relation of visceral adipose tissue accumulation to total body fatness. Am. J. Clin. Nutr. 58: 463-467.
72. Berglund, L., E. H. Oliver, N. Fontanez, S. Holleran, K. Matthews, P. S. Roheim, H. N. Ginsberg, R. Ramakrishnan, and M. Lefevre. 1999. HDL-subpopulation patterns in response to reductions in dietary total and saturated fat intakes in healthy subjects. Am. J. Clin. Nutr. 70: 992-1000.
73. Kasim, S. E., S. Martino, P. N. Kim, S. Khilnani, A. Boomer, J. Depper, B. A. Reading, and L. K. Heilbrun. 1993. Dietary and anthropometric determinants of plasma lipoproteins during a long-term low-fat diet in healthy women. Am. J. Clin. Nutr. 57: 146-153.
74. Dreon, D. M., H. A. Fernstrom, H. Campos, P. Blanche, P. T. Williams, and R. M. Krauss. 1998. Change in dietary saturated fat intake is correlated with change in mass of large low-density-lipoprotein particles in men. Am. J. Clin. Nutr. 67: 828-836.
75. Campos, H., D. M. Dreon, and R. M. Krauss. 1995. Associations of hepatic and lipoprotein lipase activities with changes in dietary composition and low density lipoprotein subclasses. J. Lipid Res. 36: 462-472.
76. Ordovas, J. M., D. Corella, S. Demissie, L. A. Cupples, P. Couture, O. Coltell, P. W. Wilson, E. J. Schaefer, and K. L. Tucker. 2002. Dietary fat intake determines the effect of a common polymorphism in the hepatic lipase gene promoter on high-density lipoprotein metabolism: evidence of a strong dose effect in this gene-nutrient interaction in the Framingham Study. Circulation. 106: 2315-2321.
77. Zambon, A., J. E. Hokanson, B. G. Brown, and J. D. Brunzell. 1999. Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density. Circulation. 99: 1959-1964.
78. Zambon, A., S. S. Deeb, B. G. Brown, J. E. Hokanson, and J. D. Brunzell. 2001. Common hepatic lipase gene promoter variant determines clinical response to intensive lipid-lowering treatment. Circulation. 103: 792-798.
79. Brunzell, J. D., and J. E. Hokanson. 1999. Dyslipidemia of central obesity and insulin resistance. Diabetes Care. 22(Suppl. 3): C10-C13.